Mr. Parker has More Than 25 Years of Commercial Leadership Experience and has Launched Multiple Rare Disease Products ...

Discover CSL Ltd's groundbreaking patent for proteins targeting the hG-CSFR receptor, paving the way for innovative antibody therapies against G-CSF signaling.

Global Biosimilar Market is valued at approximately USD 29.4 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 17.8% over the forecast period 2024-2032. Read the ...

However, omission does result in reductions in neutropenia, thrombocytopenia, and use of granulocyte colony-stimulating factor ...

Tyr Pharma has been able to make significant progress developing its lead clinical drug for the treatment of patients with ...